DocJ
Joined: 25 Mar 2004
Posts: 2
Posted: Thu Mar 25, 2004 2:31 pm Post subject: Dialysis life expetancy
--------------------------------------------------------------------------------
Does anyone have the article on the life expectancy for Dialysis patients. Please post or forward to Arlene. Thanks!
*****************************************************************
not good
Joined: 25 Mar 2004
Posts: 1
Posted: Thu Mar 25, 2004 4:23 pm Post subject: maybe this?
--------------------------------------------------------------------------------
<
>"The poor long-term survival of ESRD patients continues to be an area of concern. Expected remaining lifetimes for dialysis patients are only one-third to one-sixth those of the general U.S. population." <
><
><
>www.usrds.org 2003 Annual Data Report pg. 106 2nd column, 1st paragraph<
>
*****************************************************************
FYI
Joined: 15 Feb 2003
Posts: 72
Posted: Fri Mar 26, 2004 6:10 am Post subject: Could this answer?
--------------------------------------------------------------------------------
AMA Strongly Supports Passage of Medicare Conference Report<
><
>Blitzes Capitol Hill With Advertising and Grassroots Campaign<
><
>WASHINGTON, Nov. 16 /PRNewswire/ -- The American Medical Association today announced its strong support for the Medicare prescription drug conference report and urged Congress to pass it before they adjourn.<
><
>"We are pleased that the Medicare conferees have reached agreement on an historic Medicare bill that provides seniors with the prescription drug coverage they need and ensures that they have access to a physician when they need one," AMA President Donald J. Palmisano, M.D. said. "The bill also expands seniors' health plan choices and improves physician recruitment and retention in rural and underserved areas."<
><
>"Before members of Congress head home for Thanksgiving with their families, it is critical that they give America's seniors a Medicare bill they can be thankful for," Dr. Palmisano said.<
><
>On Monday, the AMA will unveil a new advertisement in its ongoing campaign to promote passage of a Medicare prescription drug bill that protects seniors' access to physicians. The ad, running next week in CQ Today and Roll Call, points out that "Virtually every member of Congress has campaigned on passing a Medicare bill for seniors" and asks the question, "What will they tell voters if they don't?"<
><
>Through the AMA's grassroots network, more than 10,000 physicians and patients have sent a message to Congress urging passage of a Medicare prescription drug bill. Last week's AMA Medicare ad featured three physicians and the message, "Unless Congress Does Its Job, We Can't Do Ours."<
><
>In addition to the need for a Medicare prescription drug benefit for seniors, the AMA's campaign has highlighted the need to halt the impending Medicare payment cuts to physicians and other health professionals. The Medicare conference report stops two years of impending Medicare cuts, replacing them with payment increases of at least 1.5 percent a year.<
><
>"Congress is so close to fulfilling its promise to America's seniors and disabled. We urge all members of Congress to vote for the Medicare prescription drug bill," Dr. Palmisano said.<
><
>CONTACT: Katherine Marks Hatwell, Public Information Officer, Washington<
><
>Media Relations of The American Medical Association, +1-202-789-7419<
><
>Web site:
www.ama-assn.org/<
><
>
*****************************************************************
FYI
Joined: 15 Feb 2003
Posts: 72
Posted: Sat Mar 27, 2004 4:06 pm Post subject: Or this per DOPPS
--------------------------------------------------------------------------------
New Data Demonstrate Improving Care for Dialysis Patients Could Extend Survival<
><
>Study Illustrates How Practices, Patients, and Policies Affect Patient Longevity<
><
>SAN DIEGO, Nov. 16 /PRNewswire/ -- New data presented today at the American Society of Nephrology (ASN) conference suggest that optimizing practice patterns for treating chronic kidney disease (CKD) patients receiving hemodialysis may reduce hospitalization and allow patients to live longer. However, study investigators note there are wide variations in the practices and care indicators in dialysis units around the world.<
><
>"The Dialysis Outcomes and Practice Patterns Study (DOPPS) has been able to identify treatment factors that are modifiable and that likely can lead to longer, healthier lives for dialysis patients. This study shows that longevity and quality of life varies by region and by country," said Dr. Friedrich K. Port, principal investigator for the DOPPS.<
><
>The new data reveals an association between practices, behaviors and healthcare polices that impact survival of dialysis patients, including the following:<
><
><
> * Dialysis patients, on average, are 60 years of age and, in the United States, have a life expectancy of 4.3 years after beginning dialysis.<
> * Laboratory values for many hemodialysis patients remain outside of established NKF-K/DOQI(TM) clinical practice guidelines.<
> * Anemia control has improved significantly since the start of the DOPPS study in 1997. In the U.S., Hemoglobin levels have increased from 10.8 g/dL to 11.7 g/dL in 2002. Patients whose hemoglobin level is within the guidelines show improved survival rates and lower risk of being hospitalized.<
> * The use of hemodialysis catheters for access to circulation during dialysis has increased substantially in recent years and is connected with greater risk of infections, poorer anemia control, and decreased<
>longevity.<
> * Control of phosphorus and calcium in the blood is difficult in dialysis patients, but is important for patient survival, particularly with regard to cardiovascular disease.<
> * International results on medication use revealed several opportunities to improve longevity through increased use of various medications, including multivitamins and aspirin, in patients with cardiovascular<
>disease.<
><
>"The ultimate goal of the DOPPS is to improve the longevity and quality of life for the more than 900,000 hemodialysis patients around the world," said Dr. Port, President of the University Renal Research and Education Association (URREA). "The numerous findings from the DOPPS are timely and relevant to health care providers, policy makers, and patients around the world. We are presenting numerous new and confirmatory results at this meeting and are very encouraged by the interest that has been stimulated by the DOPPS data. These findings will be key to rallying the global nephrology community around the need to better understand how to extend patients lives."<
><
>"We see the DOPPS study as having the same magnitude of impact on chronic kidney disease as the Framingham study had in the world of cardiovascular disease over the past 50 years," said Dr. Port. "The benefits for patients are already being realized and we are hopeful that our work will provide the stimulus and call to action needed to
ing optimized, life-extending care to a larger proportion of hemodialysis patients."<
><
>"The overwhelming body of evidence from the DOPPS complements the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI(TM)) and provides a deeper understanding of best practices that can improve survival," said John Davis, Chief Executive Officer of the NKF, which represents the more than 300,000 dialysis patients in the US. "The big challenge is always educating clinicians and entrenching best practices in the day-to-day care of patients. We are very hopeful that the DOPPS data will result in driving further adoption of all eight sets of NKF-K/DOQI(TM) Clinical Practice Guidelines, as it is mainly through the pursuit of optimizing total dialysis patient care that extended patient longevity will be realized."<
><
>DOPPS Design<
><
>The DOPPS is an ongoing, randomized, prospective study based on the collection of observational, longitudinal data of hemodialysis patients at more than 300 dialysis facilities in 12 countries. The study aims to identify dialysis practices that promote longer lives, reduce hospital stays and improve the quality of life for patients. In 1996, DOPPS I was launched in seven countries and in 2002 DOPPS II was extended to include a total of 12
countries. To date, the DOPPS has collected data on more than 80,000 hemodialysis patients. Researchers observe the effects of administrative practices; anemia management; dialysis practices; cardiovascular risk; mineral metabolism; physician, nursing and technician practices; proper nutrition; available social services; and vascular access on CKD.<
><
>The Dialysis Outcomes and Practice Patterns Study (DOPPS) is coordinated by research scientists and staff of the University Renal Research and Education Association (URREA) and is supported by research grants from Amgen, Inc. and Kirin Brewery Co., Ltd in Japan. Findings presented at the ASN include data from all 12 countries. DOPPS data are representative of approximately 70 percent of hemodialysis patients worldwide.<
><
>Chronic Kidney Disease (CKD)<
><
>Chronic kidney disease affects roughly 20 million people in the U.S., resulting in kidney failure, increased risk of cardiovascular events and death; another 20 million Americans are at risk for developing CKD. In 2002, according to the National Kidney Foundation, 326,217 Americans suffered from kidney failure (the final stage of CKD) and required dialysis. This number is expected to increase to an estimated 661,330 by 2010.<
><
>About URREA<
><
>URREA is a not-for-profit foundation whose purpose is to conduct epidemiological, clinical, and economic studies of kidney and related diseases. URREA is dedicated to the distribution of clinical and economic information and analysis for use by the U.S. and international health care communities. URREA is also dedicated to the education of new investigators in the field of epidemiology and outcomes research.<
><
><
>Additional Resources<
> Dialysis Outcomes and Practice Patterns Study:<
>www.dopps.org/ NKF-K/DOQI(TM):
www.kidney.org/profession.../index.cfm University Renal Research and Education Association:
www.urrea.org/ CONTACT: Research Inquiries - Ronald L. Pisoni, Ph.D., Sr. Research<
><
>Scientist, rlpisoni@urrea.org , or Media Inquiries - Kerry Colligan, Mgr.<
><
>Communications, kcolligan@urrea.org , both of University Renal Research and<
><
>Education Association, +1-734-665-4108<
><
>Web site:
www.urrea.org/<
><
>www.dopps.org/<
><
>www.kidney.org/profession.../index.cfm<
><
><
>Issued: 11/16/2003 08:00 PM GMT <
> <
>
*****************************************************************
SHIRTS
Joined: 13 Jan 2003
Posts: 39
Posted: Sat Mar 27, 2004 11:26 pm Post subject: LIFE
--------------------------------------------------------------------------------
TEN YEARS ON DIALYSIS SO FAR....AND COUNTING<
>STAY WELL
